Now playing Next Culture news David Guetta and Keinemusik among industry recipients of DJ Awards '24 The first awards have been announced ahead of the DJ Awards 2024, the highly anticipated return of the once annual awards post-Covid. 17/09/2024
Now playing Next Business Weight loss market: Eli Lilly and Novo Nordisk's rivals muscle in As Eli Lilly and Novo Nordisk continue to dominate the lucrative weight-loss drug market, smaller competitors are gearing up to release their own treatments, aiming to challenge the two industry leaders. 17/09/2024
Now playing Next Health news Women on weight loss drug lose more weight than men, study finds A new study found that women using the weight loss drug tirzepatide (Mounjaro) lost more weight than men, but experienced higher rates of side effects like nausea and vomiting. 13/09/2024
Now playing Next Health news Weight-loss drug 'safe and effective' for kids as young as 6 Novo Nordisk asked US regulators to approve the drug for children ages 6 to 11. In the EU, it's available for adolescents as young as 12. 11/09/2024
Now playing Next Israel Protesters demand deal to release Israeli hostages held in Gaza International efforts continue to try to secure a ceasefire agreement to end more than 10 months of war between Israel and Hamas. Officials from the United States, Egypt and Qatar ended two days of talks in Doha optimistic that a deal could be reached. 18/08/2024
Now playing Next Business AstraZeneca leads in valuation as it bets on cancer drugs portfolio The company has tied up with Eccogene, a Chinese biotech firm, for a new experimental weight loss drug. The weight loss market is currently dominated by Eli Lilly and Novo Nordisk. 14/08/2024
Now playing Next Culture news The best things to do and see (or watch) in Europe this week Spectacular surrealism; Netflix's Love Is Blind UK; Gerard Way's 'The Umbrella Academy'; Sziget Festival... and a film to avoid at all costs - here's what's new in Europe this weekend. 10/08/2024
Now playing Next Culture news Film of the Week: 'Borderlands' - One to avoid at all costs It's Guardians Of The Galaxy meets Mad Max - if a hyperactive toddler had reimagined them as dumpsterfires. 09/08/2024
Now playing Next Markets Weekly recap: Markets remain mixed as dip-buying gains momentum Global markets presented a mixed picture after a broad rebound on Thursday, with major indices recovering from their recent lows. Investors likely sought dip-buying opportunities following the significant sell-offs earlier in the week. 09/08/2024
Now playing Next Business Novo Nordisk: Earnings trimmed as rivals seek to enter market Novo Nordisk missed earnings expectations in the second quarter due to growing competition and increased costs from capacity expansions. The company also downgraded its profit outlook for 2024. 07/08/2024
Now playing Next Business Investors look to weight loss drugs to boost Novo Nordisk growth Novo Nordisk is releasing its second-quarter earnings on Wednesday, with analysts expecting more than 20% growth driven by Ozempic and Wegovy sales. However, the company faces challenges from more competition. 06/08/2024
Now playing Next Business Week ahead: Investors gauge the growth trajectory of Novo Nordisk Risk-off sentiment may continue to shape market trends following a turbulent week. Novo Nordisk’s earnings will be in the spotlight as investors gauge the growth trajectory of Europe’s largest company. 05/08/2024
Now playing Next Health news Weight loss drug may cut heart failure risk, company says New results from a clinical trial evaluating the drug showed positive results for reducing heart failure risk. 02/08/2024
Now playing Next Business Roche plans speedy weight-loss drug launch to catch up with rivals Roche believes its anti-obesity drugs could have advantages over other more established rivals such as Eli Lilly and Novo Nordisk through ease of scalability that will allow it to meet increased demand. 30/07/2024
Now playing Next Business AstraZeneca tops second-quarter earnings forecasts and raises guidance AstraZeneca exceeded market expectations in its second-quarter earnings report. The British pharmaceutical firm has also upgraded its guidance for fiscal year 2024. 25/07/2024
Now playing Next Markets Markets recap: Sharp retreat amid global tech wreck Major global stock markets head for a negative close for the week as blue chips fell amid sector rotations, while the semiconductor stocks were hit by expectations of the US renewed chip export curbs on China. 19/07/2024
Now playing Next The Exchange Healthcare’s AI and Robotics revolution In partnership with Media City The global healthcare sector is valued at $9 trillion, which is 11% of the world’s GDP. This mammoth market is being transformed by advances in both robotics and artificial intelligence. At the same time a range of new patient apps are empowering people to take control of their own health data. 17/07/2024